CBDV BEGINS RESEARCH ON PSILOCYBIN EXTRACTION WITH SECTION 56 EXEMPTION FROM HEALTH CANADA
CBDV will develop analytical methods for psilocybin extraction and identify new medicinally relevant mushroom metabolites. VANCOUVER, BC, CANADA, January 14 2021. Complex Biotech Discovery Ventures Ltd. (“CBDV” or the “Company”),...




